Blog

  • Introducing: B60

    Veronica Meade-Kelly, November 25th, 2014

    B60, a new video series appearing on the Broad Institute YouTube channel, is a window into Broad science and culture. Each 60-second video offers a glimpse into the innovative work taking place at the institute, and the spirit of collaboration and creativity that makes it possible. Watch the series to learn how the Broad is tackling some of the most ambitious challenges in biomedicine today.

    0 Comments
    Read More
  • Cancer gene found hiding in plain sight

    Veronica Meade-Kelly, October 27th, 2014

    A mutation that may be driving as many as 20 percent of endometrial and colorectal cancers has come to light this week, thanks to a study by researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute.

    The researchers describe finding the connection between the gene RNF43 and these cancers earlier this week in Nature Genetics.

    0 Comments
    Read More
  • Sangeeta Bhatia awarded Lemelson-MIT Prize

    Veronica Meade-Kelly, September 8th, 2014

    Broad senior associate member Sangeeta Bhatia has been named the 2014 recipient of the $500,000 Lemelson-MIT Prize. The honor, which is celebrating its 20th year, recognizes outstanding, mid-career inventors who are improving the world through technological invention, and demonstrating a commitment to mentorship in science, technology, engineering, and mathematics.

    0 Comments
    Read More
  • Finding the mutations that matter

    Veronica Meade-Kelly, August 7th, 2014

    A major endeavor in genomics research, at the Broad Institute and beyond, is to identify the variations in the human genetic code that may be associated with disease. Such variations can point to potential drug targets or shed light on the biological mechanisms underlying a disease.

    0 Comments
    Read More
  • In the news: WBUR talks with Broad scientists on “Brain Matters”

    Veronica Meade-Kelly, June 20th, 2014 | Filed under

    Steve Hyman, director of the Broad Institute’s Stanley Center for Psychiatric Research, was recently featured in WBUR’s special series “Brain Matters.” The series, which will run through July 24, aims to report “from the front lines of neuroscience,” and is exploring issues and trends in neurological and psychiatric research.

    0 Comments
    Read More
  • Eric Lander, Gad Getz listed among “the one hundred”

    Veronica Meade-Kelly, June 4th, 2014

    For the past seven years, the Massachusetts General Hospital (MGH) Cancer Center has celebrated the one hundred.” The annual fundraising event recognizes 100 individuals and organizations that are making a difference in the fight against cancer.

    0 Comments
    Read More
  • Students Ask : Broadies Answer

    Veronica Meade-Kelly, June 3rd, 2014

    The Broad’s Office of Education and Outreach, in collaboration with the Cancer Program, is putting tools used for cancer research in students’ hands.

    0 Comments
    Read More
  • Broad DREAM Challenge: Help find cancer’s vulnerabilities

    Veronica Meade-Kelly, June 2nd, 2014

    The Broad-DREAM Gene Essentiality Prediction Challenge has begun. Computational biologists and math wizards of all stripes are invited to enter the competition, which calls on statistically inclined members of the public to develop predictive computational models that reveal which genes are most essential to the survival of various cancer subtypes.

    0 Comments
    Read More
  • Now playing: Broad Paper Vids

    Veronica Meade-Kelly, May 23rd, 2014

    In the coming months, a new video series on the Broad’s popular YouTube channel will introduce viewers to published research – from the scientist’s perspective. In each installment of the “Broad Paper Vids” series, institute researchers will describe the exciting scientific discoveries that have made their way from the Broad to the pages of respected scientific journals.

    0 Comments
    Read More
  • Studies converge on ALS

    Veronica Meade-Kelly, April 4th, 2014

    What: Researchers from the Broad Institute, the Harvard Stem Cell Institute (HSCI), and Boston Children’s Hospital (BCH) used an eclectic combination of cutting-edge technologies to determine what’s going wrong at the molecular level in the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Their research, published online this week in two separate Cell journals, sheds light on the mechanisms that lead to the disease and highlights potential targets for new treatments.

    0 Comments
    Read More